Marta Sanchez-Lopez

L'hospitalet De Llobregat, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot program.

Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot program.

Journal: Medicine

Published: August 10, 2022

Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.

Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.

Journal: International journal of chronic obstructive pulmonary disease

Published: November 23, 2018

Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients.

Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients.

Journal: Scientific reports

Published: October 24, 2018

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients.

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients.

Journal: International journal of chronic obstructive pulmonary disease

Published: January 19, 2018

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.

Journal: Respiratory research

Published: January 08, 2018

Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study.

Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study.

Journal: COPD

Published: May 27, 2017

Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).

Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).

Journal: PloS one

Published: November 02, 2016

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation.

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation.

Journal: International journal of chronic obstructive pulmonary disease

Published: April 05, 2016

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.

Journal: PloS one

Published: October 27, 2015

Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.

Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.

Journal: The clinical respiratory journal

Published: July 13, 2015

Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients.

Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients.

Journal: Lung

Published: December 22, 2014

Roflumilast added to triple therapy in patients with severe COPD: a real life study.

Roflumilast added to triple therapy in patients with severe COPD: a real life study.

Journal: Pulmonary pharmacology & therapeutics

Published: June 16, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026